AI Verdict
AAPL has stronger fundamentals based on our AI analysis.
IMNM vs AAPL Fundamental Comparison
| Metric | IMNM | AAPL |
|---|---|---|
| Revenue | $6.9M | $143.8B |
| Net Income | $-212.4M | $42.1B |
| Net Margin | -3,060.0% | 29.3% |
| ROE | -33.5% | 47.7% |
| ROA | -31.1% | 11.1% |
| Current Ratio | 14.69x | 0.97x |
| Debt/Equity | 0.00x | 1.00x |
| EPS | $-2.43 | $2.84 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IMNM vs AAPL: Frequently Asked Questions
Is IMNM or AAPL a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AAPL has stronger fundamentals. IMNM is rated STRONG SELL (88% confidence) while AAPL is rated BUY (87% confidence). This is not investment advice.
How does IMNM compare to AAPL fundamentally?
Immunome Inc. has ROE of -33.5% vs Apple Inc.'s 47.7%. Net margins are -3,060.0% vs 29.3% respectively.
Which stock pays higher dividends, IMNM or AAPL?
IMNM has a dividend yield of N/A or no dividend while AAPL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IMNM or AAPL for long term?
For long-term investing, consider that IMNM has STRONG SELL rating with 88% confidence, while AAPL has BUY rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IMNM vs AAPL?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IMNM vs AAPL, the AI consensus favors AAPL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.